Pharma Forum Dialogues

New York Pharma Forum to Hold "Japan Life Sciences Showcase" - Leading Japanese Scientists Explore Partnering Opportunities in the US

New York Pharma Forum Holds Symposium on Pharma's Commitment to Global Health


The First Supreme Court Review of a Biosimilar Case

5 Most-Read Pharma Forum Dialogues Blog Posts of 2015

New York Pharma Forum Holds Symposium on the Reinvention of Pharma

American & Japanese Pharma Companies To Explore Reinvention of Pharma

The Roots of Disruptive Innovation: Healthcare and Beyond

Court Decision Clarifies Hatch-Waxman Data Exclusivity

Softgel Formulations - An Elegant Vehicle for Commercial Success

Double Your Dose of Social Media and Call Me in the Morning

New York Pharma Forum’s Top 3 Most-Read Blog Posts of 2014

FDA Adopts New Procedures for Evaluating Names of Drug Products

Impact of the U.S. Foreign Corrupt Practices Act on Japanese Pharma

New York Pharma Forum 25th General Assembly: "The Future of Aging"

NY Attorney General Sues Forest Laboratories for “Product Hopping”

Japanese Drug Industry's &
Big Pharma's 25-Year Journey

Happy Birthday, New York Pharma Forum!

Two FDA Citizen Petitions Granted Regarding Manufacturer Speech

FDA Releases Draft Guidance on New Risk Information for Approved Drugs

Pain Drug Development to Address High Unmet Need

Background on and Trends in Ethnic Bridging Studies

Inter Partes Review Adds
Another Twist To Hatch-Waxman Litigation

Welcome to the Pharma Forum Dialogues Blog